310 results
Page 14 of 16
6-K
EX-99
ns8472gzo 7ik
16 Oct 12
BioLineRx Announces Successful Completion of Pre-Clinical
12:00am
424B3
5jdbgd1bux qnnttu1
15 Oct 12
Prospectus supplement
12:00am
6-K
EX-99
idw3tu6c6sqx3dpoq
9 Oct 12
BioLineRx Announces New Analysis of EAGLE Phase IIb
12:00am
F-1
7fvc 8ojl8kt3jz4mxq
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99.1
qrxl284 b0zqkd
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
wvix8or
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
2d798z 0cwpds13m
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
db77hr5j4
24 Sep 12
BioLineRx Receives Notice of Allowance from USPTO
12:00am
S-8
EX-3.1
ji7s4jtof8zmg2uq
19 Sep 12
Registration of securities for employees
12:00am
6-K
EX-99
05d891y8co0y9n05
10 Sep 12
BioLineRx Announces Pre-clinical Results Demonstrating
12:00am
6-K
EX-99.1
xbxbbnj62ttg
4 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
r74uw2wms6vd2w4ha
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
F-3/A
huuqte4l8 myt7rgyb
13 Aug 12
Shelf registration (foreign) (amended)
12:00am
F-3
0f8l 6ms3bcwn6rudosj
1 Aug 12
Shelf registration (foreign)
12:00am
POS AM
b1nn9
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
79t0mla
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
6-K
EX-99
nb6kzhjn64p2p
9 Jul 12
BioLineRx Receives Notice of Intention to Grant
12:00am
6-K
EX-99
ocsf3g 0k
5 Jun 12
BioLineRx Announces Receipt of Two Notices of
12:00am
6-K
EX-99
shgld50
25 Apr 12
BioLineRx Announces Extension of Patent
12:00am
424B3
zbiszkun
28 Mar 12
Prospectus supplement
12:00am